knowledge -WSS

knowledge

author：hotspot 2025-09-27 12:56:21 - browse：29

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — This week, European regulators are considering an appeal from Amylyx Pharmaceuticals after initially recommending against approving the company’s ALS treatment — the latest potential turning point for a drug that has seen its share of ups and downs with regulatory bodies.

In June, a European Medicines Agency committee issued a negative review of Amylyx’s drug, called Albrioza, and cast doubt on whether it had demonstrated effectiveness in its pivotal study. That would have almost certainly led to a rejection by regulators, but Amylyx requested what’s called a re-examination of the opinion. On Tuesday, the EMA held a meeting on the appeal, and a decision is expected in the coming weeks.

“There are patients who are dying and they really want access to the drug,” said Evy Reviers, the chairwoman of the European Organization for Professionals and Patients with ALS, whose father has the neurological disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Data don't support strong claims for Covid

WSS

Apellis safety probe of eye disease drug centers on injection needle

Psilocybin's anti

Complete sequence of Y chromosome published for first time

Finland to offer bird flu vaccine to select groups of people, a possible global first

An outdated Medicare rule harms dementia patients with anxiety

AstraZeneca challenges Medicare drug negotiation program

entertainment

knowledge

knowledge

Walensky prepares to leave CDC — and Congress — behind

As pharma fights Medicare drug negotiation, hospitals, docs silent

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

ASCO Takeaways: Winners, snoozers, and the art of cancer care

Medicare proposal to cover medical devices draws a mixed reaction

Australia’s approach to dialysis celebrates life

Jerome Adams on the need for new antivirals for Covid

Take antibiotics after sex, CDC recommends for certain risk groups

Alkermes shareholders re

Eli Lilly’s Zepbound improved liver scarring in mid

knowledge

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

Study finds new variant for Parkinson’s in African populations

As pharma fights Medicare drug negotiation, hospitals, docs silent

ASCO Takeaways: Winners, snoozers, and the art of cancer care

Australia’s approach to dialysis celebrates life

Senators tussle over abortion against the backdrop of a presidential campaign

focus

entertainment

entertainment

hotspot